Cisplatin cardiomyopathy

Author: znni

August undefined, 2024

WebThis study has been initiated to investigate whether endogenous carnitine depletion and/or carnitine deficiency is a risk factor during development of cisplatin (CDDP)-induced cardiomyopathy and if so, whether carnitine supplementation by propionyl-L-carnitine (PLC) could offer protection against this toxicity. WebSummary: Congestive cardiomyopathy is found among people who take Cisplatin, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months. The phase IV clinical study analyzes which people take Cisplatin and have Congestive cardiomyopathy. It is created by eHealthMe based on reports of 79,691 people who …

Gemcitabine-induced cardiomyopathy: a case report and review …

WebNational Center for Biotechnology Information WebMar 12, 2015 · We previously demonstrated that the increase in troponin I (TnI) soon after high-dose chemotherapy (HDC) is a strong predictor of left ventricular dysfunction and poor cardiac outcome, particularly in patients showing a persistent TnI increase. 5,6 This finding has important clinical implications and allows the identification of patients at high risk of … how do you start investing in gold

Chemotherapy Agents That Cause Cardiotoxicity - U.S.

WebApr 21, 2024 · If you’re receiving carboplatin or cisplatin chemotherapy, talk to your doctor about the risks to your hearing. Heart problems Chemotherapy can lead to high blood … WebAfter right heart catheterization, pathological results of a myocardial biopsy from the ventricular septum indicated no cardiac muscle hypertrophy, cardiac fibrosis, … WebAcute clinical syndromes associated with cisplatin infusion include chest pain, palpitations, and, occasionally, elevated cardiac enzymes indicative of myocardial infarction (MI). 16 … how do you start investing in penny stocks

UpToDate

WebCisplatin can induce direct myocardial toxicity leading to atrial fibrillation whereas the potential of myocardial toxicity is amplified when the drug is administered in … WebJan 1, 2013 · Patients receiving cisplatin-based chemotherapy may experience coronary artery diseases, arrhythmias, and cardiomyopathy 3). Moore et al. have reported cases of arterial thrombosis with subsequent ... phones that use wifiWebApr 11, 2024 · Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and … how do you start knitting

"WebAlthough cisplatin (cisPt) is one of the most often used cytotoxic drugs in the treatment of cancer, its clinical application is associated with nephrotoxicity 掌桥科研一站式科研服务平台 " - Cisplatin cardiomyopathy

Cisplatin cardiomyopathy

Cardiotoxicity of cisplatin-based chemotherapy in advanced non …

WebOct 11, 2024 · Weakening of the heart muscle (cardiomyopathy) Heart rhythm problems (arrhythmia) Heart attack Stroke High blood pressure Blood clots Whether you're at risk … WebCisplatin-induced cardiotoxicity is a well describe effect with a low incidence. Supraventricular arrhythmias and coro-nary artery disease are the main cardiac effects. ... Cardiotoxicity secondary to cisplatin administration manifests as both delayed effects (mainly as chronic ischemic cardiomyopathy and arterial hypertension) and acute ...

Did you know?

WebOct 1, 2013 · Chemotherapy may induce entire spectrum of cardiac pathology. Cisplatin (CDDP) is a widely used chemotherapeutic agent and its use is limited by its wide range of toxicities, most common being renal and neurotoxicity. Cardiotoxicity of cisplatin is less common and may range from silent and symptomatic arrhythmias to cardiomyopathy … WebCytostatic antibiotics of the anthracycline class are the best known of the chemotherapeutic agents that cause cardiotoxicity. Alkylating agents such as cyclophosphamide, ifosfamide, cisplatin, carmustine, busulfan, chlormethine and mitomycin have also been associated with cardiotoxicity.

WebWARNING: CARDIOMYOPATHY, INFUSION REACTIONS, EMBRYO-FETAL TOXICITY, and PULMONARY TOXICITY See full prescribing information for complete boxed warning Cardiomyopathy: trastuzumab products can result in subclinical and clinical cardiac ... Cisplatin was administered at 80 mg/m on Day 1 and the WebAug 1, 2012 · Traditional and novel chemotherapy agents can damage the heart or peripheral blood vessels, or cause problems with clotting or blood lipids. Some …

WebJun 23, 2014 · Cardiomyopathy after the use of gemcitabine monotherapy is extremely rare; and only one such case has been reported in detail previously. ... Barton C, Ghahramani P, Hirsh V: Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. Ann Oncol. 2004, 15: 19-27. … WebChemotherapeutic drugs can cause cardiac toxicities such as cardiomyopathy, arrhythmia, and cardiovascular disease. The well-known side effects of cisplatin are nephrotoxicity, nausea, vomiting, and electrolyte imbalance. Cardiotoxicity induced by cisplatin is rare, and its pathophysiology is unknown.

WebMay 4, 2024 · Signs and symptoms of dilated cardiomyopathy may include: Fatigue. Shortness of breath (dyspnea) during activity or while lying down. Reduced ability to exercise. Swelling (edema) in the legs, ankles, …

WebOct 6, 2024 · The following are common signs of cardiomyopathy: Trouble breathing when you’re active or resting. Some people might also need to sleep sitting up or with many pillows under their head to help them … phones that walmart sellsWebNational Center for Biotechnology Information how do you start learning russianWebApr 2, 2024 · Cardiomyopathy (kahr-dee-o-my-OP-uh-thee) is a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body. Cardiomyopathy can lead to heart failure. The main types … how do you start investing in mutual fundsWebJun 1, 2013 · Cardiotoxicity is a well known consequence of cancer chemotherapy. Cisplatin-based combinations are standard regimens in the therapy of advanced non-small cell lung cancer. Administration of cisplatin-containing chemotherapy causes significant oxidative and nitrosative stress in some patients. how do you start llcWebDec 6, 2024 · weakness in the arms, hands, legs, or feet Less common Blood in the urine or stools difficult or labored breathing pinpoint red spots on the skin shortness of breath (severe) slow heartbeat tightness in the chest wheezing Incidence not known Anxiety blue lips, fingernails, or skin difficult or troubled breathing fainting fast heartbeat phones that will work on attWebApr 11, 2024 · The package insert for Adriamycin states that lifetime cumulative doses above 550 mg/m2 (21-day cycles) are associated with an increased risk of cardiomyopathy. In people at higher risk of cardiotoxicity, the maximum cumulative dose of doxorubicin should be limited to less than 400. how do you start lspdfrWebJul 23, 2024 · Clinical implication of Cisplatin (cis-dichlorodiammine-platinum (II), CP) is restricted owing to augmented oxidative stress and apoptosis that have been involved in cardiac injury. Cisplatin usage is also associated with the cardiotoxicity including arrhythmia, myocarditis, cardiomyopathy and congestive heart failure [1,2,3,4,5]. phones that work in canada